Design, Synthesis and Molecular Docking of 1,3,4‐Oxadiazole‐2(3<i>H</i>)‐thione Derivatives Containing 1,4‐Benzodioxane Skeleton as Potential FabH Inhibitors
Juan Sun, Cuiping Zhang, Chong‐Hao Chen, Xiaomeng Guo, Cai‐Shi Liu, Yang Zhou, Fuliang Hu
Abstract
Abstract Fatty acid biosynthesis is essential for bacterial survival. Of these promising targets, β ‐ketoacyl‐acyl carrier protein (ACP) synthase III (FabH) is the most attractive target. A series of novel 1,3,4‐oxadiazole‐2(3 H )‐thione derivatives containing 1,4‐benzodioxane skeleton targeting FabH were designed and synthesized. These compounds were determined by 1 H‐NMR, 13 C‐NMR, MS and further confirmed by crystallographic diffraction study for compound 7m and 7n . Most of the compounds exhibited good inhibitory activity against bacteria by computer‐assisted screening, antibacterial activity test and E. coli FabH inhibitory activity test, wherein compounds 7e and 7q exhibited the most significant inhibitory activities. Besides, compound 7q showed the best E. coli FabH inhibitory activity (IC 50 =2.45 μΜ). Computational docking studies also showed that compound 7q interacts with FabH critical residues in the active site.